Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | BDC-3042 |
Synonyms | |
Therapy Description |
BDC-3042 is an agonistic antibody that targets Dectin-2 (CLEC6A) to induce a pro-inflammatory immune response, potentially resulting in decreased tumor growth (Cancer Res (2023) 83 (7_Supplement): 2964). |